# Outcomes of MF Patients Exposure to Ruxolitinib During Transplantation

> **NCT04526223** · NA · UNKNOWN · sponsor: **xuna** · enrollment: 30 (estimated)

## Conditions studied

- Time of Hematopoietic Reconstruction

## Interventions

- **OTHER:** comprehensive treatment regimen

## Key facts

- **NCT ID:** NCT04526223
- **Lead sponsor:** xuna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-20
- **Primary completion:** 2022-12-20
- **Final completion:** 2022-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04526223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04526223, "Outcomes of MF Patients Exposure to Ruxolitinib During Transplantation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04526223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*